Table 3.
Symptoms and Signs | 0–2 Weeks Acute Phase | 2 Weeks–3 Months | 3–6 Months | 6–12 Months |
---|---|---|---|---|
(n = 53) | (n = 42) | (n = 15) | (n = 18) | |
(%) | (%) | (%) | (%) | |
Headache | 43 (81) | 9 (21) | 2 (13) | 2 (11) |
Sensitivity to light/sound | 8 (15) | 1 (2) | 2 (13) | 1 (6) |
Radiculitis | 17 (32) | 6 (14) | 1 (7) | 0 |
Cranial nerve affection | 19 (36) | 3 (7) | 3 (20) | 1 (6) |
Spinal nerve paresis | 18 (34) | 17 (40) | 8 (53) | 8 (44) |
Dysphasia | 30 (57) | 3 (7) | 2 (13) | 2 (11) |
Apraxia | 11 (21) | 1 (2) | 0 | 0 |
Ataxia | 38 (72) | 26 (62) | 9 (60) | 4 (22) |
Epilepsy | 8 (15) | 1 (2) | 0 | 0 |
Concentration disability | 43 (81) | 22 (52) | 8 (53) | 7 (39) |
Memory disturbance | 32 (60) | 17 (40) | 8 (53) | 6 (33) |
Fatigue | 52 (98) | 33 (79) | 13 (87) | 8 (44) |
Emotional lability | 12 (23) | 17 (40) | 8 (53) | 6 (33) |
Total | 53 (100) | 33 (79) | 13 (87) | 8 (44) |